Watchlist Price Alert

Vir Biotechnology Inc. (VIR)

NASDAQ: VIR · Real-Time Price · USD

5.35

0.20 (3.88%)

At close: Jun 06, 2025, 10:06 AM

Vir Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	312.33M	241.58M	848.63M	347.81M	436.57M	109.33M	47.6M	187.92M
Short-Term Investments	678.05M	1.28B	1.55B	360.33M	300.29M	274.1M	50.84M	n/a
Long-Term Investments	190.01M	105.28M	23.93M	201.39M	12.62M	24.29M	7.67M	1M
Other Long-Term Assets	18.42M	18.86M	-228.5M	-87.07M	15.75M	15.85M	7.67M	1.26M
Receivables	n/a	n/a	n/a	773.08M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	8.59M	n/a	n/a	n/a	n/a
Other Current Assets	52.08M	65.82M	59.2M	8.59M	27.51M	13.38M	10.76M	n/a
Total Current Assets	1.04B	1.59B	2.52B	1.56B	772.37M	403M	117.78M	192.35M
Property-Plant & Equipment	122.86M	167.2M	188.17M	130.05M	79.89M	16.31M	12.29M	5.14M
Goodwill & Intangibles	25.06M	39.5M	49.69M	50.22M	50.76M	52.63M	53.85M	52.82M
Total Long-Term Assets	356.36M	330.83M	283.01M	391.45M	146.4M	109.08M	73.81M	59.22M
Total Assets	1.4B	1.92B	2.8B	1.95B	918.76M	512.07M	191.6M	251.57M
Account Payables	5.08M	6.33M	6.42M	6.52M	5.08M	5.88M	6.47M	4.9M
Deferred Revenue	12.65M	64.85M	15.52M	98.21M	6.45M	6.18M	8.76M	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	90.34M	9.35M	7.65M	96.83M	10.6M	37.5M	22.02M	n/a
Total Current Liabilities	119.66M	175.41M	511.03M	341.24M	99.06M	59.21M	39.91M	12.44M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	38.63M	40.22M	32.8M	25.36M	29.22M	12.95M	10.84M	10.4M
Total Long-Term Liabilities	128.77M	153.42M	213.1M	181.18M	102.84M	28.92M	330.87M	308.04M
Total Liabilities	248.43M	328.82M	724.13M	522.42M	201.91M	88.13M	370.77M	320.48M
Total Debt	97.89M	124.54M	127.97M	133.56M	66.56M	237K	10.14M	n/a
Common Stock	14K	13K	13K	13K	13K	11K	1K	1K
Retained Earnings	-759.78M	-237.82M	377.24M	-138.6M	-667.18M	-368.52M	-193.84M	-77.95M
Comprehensive Income	-1.72M	-815K	-9.12M	-1.1M	-1.28M	-601K	-14K	-292.52M
Shareholders Equity	1.15B	1.59B	2.08B	1.43B	716.85M	423.94M	-179.18M	-68.92M
Total Investments	868.07M	1.39B	1.55B	561.72M	300.29M	298.39M	50.84M	1M